title: Infliximab reverses progressive deafness.
authors.affiliation: Assistance publique-hôpitaux de Paris, Hospital Cochin, université Paris 5-René-Descartes, National Referral Center for Rare Autoimmune and Systemic Diseases, Department of Internal Medicine, Inserm U1060, 75679 Paris cedex 14, France.
authors.forename: Raphaël
authors.initials: R
authors.lastname: André
authors.affiliation: Assistance publique-hôpitaux de Paris, Hospital Cochin, université Paris 5-René-Descartes, National Referral Center for Rare Autoimmune and Systemic Diseases, Department of Internal Medicine, Inserm U1060, 75679 Paris cedex 14, France.
authors.forename: Pascal
authors.initials: P
authors.lastname: Corlieu
authors.affiliation: Assistance publique-hôpitaux de Paris, Hospital Cochin, université Paris 5-René-Descartes, National Referral Center for Rare Autoimmune and Systemic Diseases, Department of Internal Medicine, Inserm U1060, 75679 Paris cedex 14, France.
authors.forename: Yoann
authors.initials: Y
authors.lastname: Crabol
authors.affiliation: Assistance publique-hôpitaux de Paris, Hospital Cochin, université Paris 5-René-Descartes, National Referral Center for Rare Autoimmune and Systemic Diseases, Department of Internal Medicine, Inserm U1060, 75679 Paris cedex 14, France.
authors.forename: Pascal
authors.initials: P
authors.lastname: Cohen
authors.affiliation: Assistance publique-hôpitaux de Paris, Hospital Cochin, université Paris 5-René-Descartes, National Referral Center for Rare Autoimmune and Systemic Diseases, Department of Internal Medicine, Inserm U1060, 75679 Paris cedex 14, France. Electronic address: loic.guillevin@cch.aphp.fr.
authors.forename: Loïc
authors.initials: L
authors.lastname: Guillevin
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018450:Disease Progression; D005260:Female; D006319:Hearing Loss, Sensorineural / Q000517:prevention & control*; D006801:Humans; D000069285:Infliximab; D055815:Young Adult
chemical_list: D000911:Antibodies, Monoclonal; D000069285:Infliximab